n 87-year-old woman presented to the emergency department three hours after acute onset of left hemiplegia, profound neglect and dysarthria (severe stroke; National Institutes of Health Stroke Scale [NIHSS] = 18). Noncontrast computed tomography (CT) of the head showed early ischemic changes in the right putamen and insula, along with a hyperdense right middle cerebral artery (MCA) sign (i.e., hyperdense clot in the right M1 segment of the MCA). Computed tomog raphy angiography showed occlusion of the right internal carotid artery terminus, with good collateral circulation in the right MCA territory (for CT images, see Appendix 1, available at www.cmaj.ca/lookup/ suppl/doi:10.1503/cmaj. 150633/-/DC1). Intravenous tissue plasminogen activator was administered 30 minutes after arrival.
Given her clinical status and favourable imaging results ("good-scan-occlusion paradigm," 1 i.e., moderate to severe stroke, large-vessel occlusion, minimal early ischemic changes and good collateral circulation), the patient was considered a suitable candidate for intra-arterial thrombectomy. She was immediately transferred to the angiography suite, where catheter angiography of the neck and head indicated occlusion of the right mid-to-distal M1 segment of the right MCA ( Figure 1A) .
We performed mechanical thrombectomy by positioning a stent-retriever thrombectomy device in the distal M1 segment of the right MCA, alongside the target thrombus. The stent was deployed for five minutes before being gradually retrieved, along with the captured blood clot ( Figure 1B) . Postprocedural angiography showed complete recanalization of the right MCA (Appendix 2, available at www.cmaj.ca/lookup/ suppl/doi:10.1503/cmaj.150633/-/DC1), achieved about 17 minutes after inguinal puncture. Head CT performed 24 hours after reperfusion showed no major complications. The patient's left hemiplegia diminished markedly, and she was discharged on day 12, with minimal residual weakness and dysarthria (NIHSS = 6).
Numerous studies have emphasized the effectiveness of timely intra-arterial thrombectomy with stent-retriever devices, combined with intravenous tissue plasminogen activator, in markedly improving functional outcome 2 and reducing mortality 3 among patients with stroke. These landmark randomized clinical trials provide evidence for a more rapid rate of recanalization of large-vessel occlusion relative to tissue plasminogen activator alone, sometimes within minutes. 4 Researchers consider the remarkable potency of this procedure as a major breakthrough in the disease, offering a safe and efficient treatment for severe stroke. 
